Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Holding PHAT?
Track your performance easily

Phathom Pharmaceuticals (PHAT) Financial Statements

283 Followers

Phathom Pharmaceuticals Financial Overview

Phathom Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.693; its P/E ratio is -2.96; Phathom Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-1.20. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 16.35M$ 7.32M$ 1.91M$ 682.00K-
Gross Profit$ 14.00M$ 5.95M$ 1.49M$ 515.00K-
EBIT$ -85.58M$ -73.68M$ -65.68M$ -66.54M$ -33.14M
EBITDA$ -84.80M$ -72.98M$ -65.00M$ -66.36M$ -33.02M
Net Income Common Stockholders$ -85.58M$ -91.45M$ -82.85M$ -79.57M$ -43.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 334.68M$ 276.24M$ 322.23M$ 381.39M$ 213.68M
Total Assets$ 387.04M$ 319.38M$ 356.50M$ 413.84M$ 236.99M
Total Debt$ 176.41M$ 175.28M$ 150.04M$ 139.03M$ 100.61M
Net Debt$ -158.27M$ -100.96M$ -172.18M$ -242.36M$ -113.07M
Total Liabilities$ 574.16M$ 553.21M$ 505.00M$ 486.60M$ 254.76M
Stockholders Equity$ -187.11M$ -233.83M$ -148.50M$ -72.76M$ -17.77M
Cash Flow-
Free Cash Flow$ -63.62M$ -70.77M$ -69.06M$ -44.27M$ -32.85M
Operating Cash Flow$ -63.57M$ -70.72M$ -69.02M$ -43.80M$ -31.91M
Investing Cash Flow$ -44.00K$ -46.00K$ -40.00K$ -475.00K$ -939.00K
Financing Cash Flow$ 122.06M$ 24.77M$ 9.90M$ 211.99M$ 13.00K
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History

Phathom Pharmaceuticals Debt to Assets

Phathom Pharmaceuticals Cash Flow

Phathom Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis